Dexcom OverviewDexcom EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DXCM.
Quarterly EBIT
$255.30M
↑ 90.95% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$1.03B
↑ 63.82% YoY
Trailing 12 months ending Mar 31, 2026
Dexcom OverviewEBIT (Earnings Before Interest and Taxes) analysis for DXCM.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026